FEATURES

Shire Rejects Unsolicited Bid from Takeda as Allergan Opts to Withhold its Own Offer

DUBLIN, Ireland—Shire plc, which markets the dry eye treatment Xiidra, found itself in the middle of what looked like a takeover tussle with two other big pharma companies early on Thursday.

Read more...


Luxottica Execs See China Approval ‘Soon,’ Stockholders Appoint New Board at General Meeting

MILAN—The stockholders of Luxottica approved its statutory 2017 year-end statements and appointed a new board at its general stockholders’ meeting held here Thursday.

Read more...


MOST READ STORIES

CURRENT
ISSUE

April 2018

  • Table of Contents
  • Cover Story
  • Issue Archives
April 2018